Cancer remains a lethal disease, and many scientists are currently trying to develop more effective therapies. Natural compounds are potential sources of anti-cancer therapies and are obtained from diverse sources including marine organisms, microorganisms and plants. In this paper, we evaluated natural compounds from non-edible plant sources, which is a neglected area of research despite the promising future of these compounds. In addition, we assessed the function and mechanism of action of these compounds in relation to cancer chemoprevention. (J Cancer Prev 2014;19:1-6) 
INTRODUCTION
Cancer caused 7.6 million deaths in 2008, and it is estimated that it will cause 13. Natural products serve as a novel source for the development of anti-cancer drugs because of their unique structural diversity. 1 The current sources of natural products are more diversified than they have been in the past and include plants, marine organisms and microorganisms. [2] [3] [4] Since recently, natural compounds from marine organisms have been investigated actively and already improved cancer therapy. 5, 6 However, many scientists focus particularly on the effects of natural products in cancer chemoprevention, because of the difficulty to treat advanced forms of cancer.
Plants remain a prominent source of natural products for cancer chemoprevention, which is supported by the fact that 25% of current therapies on the market are derived from plants. 4, 7 Unfortunately, however, while many papers discuss the cancer prevention potential of food-related plants, very little is known about compounds from non-food plants including terrestrial and marine sources.
The aim of this review is to document the molecular mechanisms by which these less investigated compounds interfere with the initiation and promotion of cancer to prevent the development of cancer. Cragg's review paper, we searched for the source of each approved drug manually because the authors simply divided drug sources into B (biological), N (natural product), ND (derived from a natural product), S (synthetic drug) and V (vaccine). We identified the source of each approved anti-cancer drug as an edible or non-edible plant using DrugBank and Drug information portal sites.
THE CATEGORIZATION OF NATURAL COMPOUNDS FROM PLANTS
We finally categorized all approved anti-cancer drugs by dividing them into edible and non-edible plants sources (Table 1 
THE EFFECT OF NATURAL COMPOUNDS FROM NON-EDIBLE PLANT SOURCES ON CANCER CHEMOPREVENTION
The process of tumorigenesis consists of at least three steps: initiation, promotion, and progression 9 suggesting that cancer progresses over a long period of time. Initial efforts of many groups to cure cancer were mainly focused on the terminal stages of cancer. However, this strategy was ineffective because cancer cells have already become wide-spread throughout the body and are very resistant to anti-cancer drugs. Accordingly, the trend in the treatment of cancer is moving from cancer chemotherapy to chemoprevention, which focuses on the initiation or promotion steps of cancer. Cancer chemoprevention may also reverse chemo-and radio-resistance in cancer patients. 10 Therefore, cancer chemoprevention is not only valuable alone but can also be used as an adjuvant for chemotherapy. Table 1 shows that anti-cancer drugs from plant sources were essentially used the field of cancer chemotherapy.
Thus, natural compounds from non-edible plant sources should be evaluated for their efficacy in chemoprevention (Fig. 1) .
Artemisinin (Fig. 1A) is isolated from the leaves of the Artemisia annua, which is a common type of wormwood, and this compound inhibits transferrin receptors in cancer cells. Cancer cells uptake large amounts of ions because of their rapid metabolic rates. 11 Transferrin receptors are expressed at especially high levels in breast cancer and leukemia compared to normal cells. Accordingly, artemisinin may have prominent anticancer effects in the early stages of these types of cancer. An early study showed that artemisinin prevents and delays the development of breast cancer and leukemia by interrupting ion absorption. 12 In addition, artemisinin has no known side effects at high dose concentrations, so it would be worthwhile to study its effects on the early stages of cancer.
β-lapachone (Fig. 1B) is found in the bark of the lapacho tree, and it has been shown to inhibit tumor necrosis factor-α (TNF-α)-induced nuclear factor κB (NF-κB)
and Activator Protein 1 (AP-1) in U937 leukemic cells. methylation in malignant glioma cells. 15 Subsequently, it was discovered that NDGA lowers the methylation levels of many important tumor suppressor genes including E-cadherin and p16. 15, 16 Noscapine (Fig. 1D) is isolated from the Papaveraceae family and has been shown to induce apoptosis by down-regulating survivin expression. Survivin negatively regulates apoptosis or programmed cell death by inhibiting caspase activation. 17 In previous studies, noscapine induced apoptosis of neuroblastoma cell lines without affecting p53. Instead, noscapine decreased the expression of survivin sensitizing neuroblastoma cells to apoptosis, suggesting a novel molecular mechanism.
Shikonin ( Fig. 1E) can be purified from root of Lithospermum erythrorhizon, which is native to America. Shikonin affects the "Warburg effect" of cancer, when cancer cells produce energy through increased rates of glycolysis followed by lactic acid fermentation. 18 Pyruvate kinase M2 (PKM2) is one of the most important metabolic enzymes that regulate this pathway. According to a previous study, levels of PKM2 are much higher in skin tumor tissues than in normal tissues. 19 In this research, shikonin inhibited (Fig. 2) .
Because of their mechanism of action, cancer chemopreventive drugs function synergistically when administered with chemotherapeutic drugs, providing even more support for the need for continued research in this field.
